Malfertheiner P, Büchler M
Department of Internal Medicine and Gastroenterology, University of Ulm, West Germany.
Radiol Clin North Am. 1989 Jan;27(1):51-64.
Chronic pancreatitis is a slowly progressive disease. Initially, only focal changes occur, but diffuse structural abnormalities accompanied by various degrees of functional impairment are seen in the late stage. Morphological abnormalities in chronic pancreatitis can now be detected with high accuracy by several imaging methods. The most sensitive method is ERP, which is able to detect slight ductal changes at an early stage. High-resolution US has become a valid alternative to CT for the visualization of parenchymal abnormalities. However, CT is more accurate than US in detecting small cysts and calcifications. By comparing ductal abnormalities (ERP) and parenchymal lesions (CT, US) with pancreatic function impairment, it has become quite clear that the morphofunctional correlation is tight only in the "late" or severe stages of chronic pancreatitis. In "early" or "moderate" stages of chronic pancreatitis, correlation of the degree of morphological abnormalities and pancreatic dysfunction is frequently poor. Studies comparing the value of the different imaging methods with pancreatic function tests in the diagnosis of chronic pancreatitis have found ERP and the duodenal intubation SC test to have the highest diagnostic accuracies. Correlation between the degree of ductal abnormalities (ERP) and pancreatic dysfunction in the SC test, and between the degree of parenchymal abnormalities (CT and US) and the SC test both proved significant. However, prediction of exocrine function based on morphological alterations, or vice versa, is not possible. The value of combining function testing with imaging is enhancement of the diagnostic accuracy in the presence of only "mild" morphologic abnormalities detected with the imaging techniques. In advanced stages of chronic pancreatitis, function testing is a valid complementary tool to characterize the clinical stage of the disease and may have an impact on therapeutic decisions in patients with advanced stages of chronic pancreatitis. Invasive function testing (SC test) can be replaced by oral pancreatic function tests, which yield equivalent results or clinical decisions.
慢性胰腺炎是一种缓慢进展的疾病。起初,仅出现局灶性改变,但在后期会出现弥漫性结构异常,并伴有不同程度的功能损害。目前,几种成像方法能够高精度地检测出慢性胰腺炎的形态学异常。最敏感的方法是内镜逆行胰胆管造影(ERP),它能够在早期检测到轻微的导管改变。高分辨率超声已成为用于观察实质异常的CT的有效替代方法。然而,在检测小囊肿和钙化方面,CT比超声更准确。通过将导管异常(ERP)和实质病变(CT、超声)与胰腺功能损害进行比较,很明显形态功能相关性仅在慢性胰腺炎的“晚期”或严重阶段紧密。在慢性胰腺炎的“早期”或“中度”阶段,形态学异常程度与胰腺功能障碍之间的相关性通常较差。比较不同成像方法与胰腺功能测试在慢性胰腺炎诊断中的价值的研究发现,ERP和十二指肠插管胰泌素-促胰液素(SC)试验具有最高的诊断准确性。SC试验中导管异常程度(ERP)与胰腺功能障碍之间的相关性,以及实质异常程度(CT和超声)与SC试验之间的相关性均被证明具有显著性。然而,基于形态学改变预测外分泌功能,反之亦然,是不可能的。将功能测试与成像相结合的价值在于,在成像技术仅检测到“轻度”形态学异常的情况下提高诊断准确性。在慢性胰腺炎的晚期,功能测试是用于表征疾病临床阶段的有效补充工具,并且可能会影响慢性胰腺炎晚期患者治疗决策。侵入性功能测试(SC试验)可以被口服胰腺功能测试所取代,后者能产生等效结果或临床决策。